Norovirus -specific T-cell (NST) therapy ( DrugBank: - )


1 disease
告示番号疾患名(ページ内リンク)臨床試験数
65原発性免疫不全症候群1

65. 原発性免疫不全症候群


臨床試験数 : 500 薬物数 : 614 - (DrugBank : 119) / 標的遺伝子数 : 92 - 標的パスウェイ数 : 217
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT04691622
(ClinicalTrials.gov)
March 17, 202228/12/2020Adoptive T Lymphocyte Administration for Chronic Norovirus Treatment in Immunocompromised HostsAdoptive T Lymphocyte Administration for Chronic Norovirus Treatment in Immunocompromised HostsViral Infection;Hematopoietic Stem Cell Transplantation (HSCT);Primary Immunodeficiency Disorders (PID)Biological: Norovirus -specific T-cell (NST) therapyChildren's National Research InstituteNULLRecruiting3 Months80 YearsAll48Phase 1United States